Patent ID: 7317031

Claim:
A method for treating a kinase mediated disorder selected from the group consisting of cervical adenocarcinoma, melanoma, ovarian adenocarcinoma, colon carcinoma, prostate adenocarcinoma, and breast cancer, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of the following formula: wherein R 4 is selected from the group consisting of: —SO 2 —, substituted with one substituent selected from the group consisting of thienyl, imidazolinyl, triazolyl and amino, wherein amino is substituted with two substituents independently selected from the group consisting of hydrogen, C 1-8 alkyl, —C 1-8 alkylamino, wherein amino is substituted with two substituents independently selected from the group consisting of hydrogen and C 1-8 alkyl, thienyl, imidazolinyl, and triazolyl; or triazolyl; X is selected from the group consisting of —C(O)—, —C(S)— and —SO 2 —; and, R 3 is selected from the group consisting of: cycloalkyl, thienyl, imidazolinyl, triazolyl, and phenyl, wherein cycloalkyl, thienyl, imidazolinyl, triazolyl, and phenyl are optionally substituted with 1 to 3 substituents independently selected from the group consisting of cyano, halo, hydroxyl, nitro, C 1-8 alkyl, C 2-8 alkenyl, or C 1-8 alkoxy; and pharmaceutically acceptable salts thereof.